Dr. Connie Yang, BC Children’s Hospital, Vancouver, BC

This presentation will review the latest CTS Guideline on the Management of Very Mild and Mild Asthma in Children and Adults. It will discuss the recommendations involving ICS-formoterol as needed, ICS-short acting beta agonist as needed and short courses of inhaled corticosteroids. It will compare the CTS recommendations to other recent guidelines and strategies.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Understand the evidence for ICS-formoterol PRN versus SABA in very mild asthma;
  • Understand the evidence for ICS-formoterol PRN versus daily inhaled corticosteroids in mild asthma; and
  • Understand the rationale for recommendations involving ICS-short acting beta agonist and short courses of inhaled corticosteroids.

CanMEDs Competencies addressed:
Collaborator, Health Advocate, Medical Expert, Scholar